NASDAQ : VIR
Vir Biotechnology, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 11.75 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.99B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Vir Biotechnology, Inc. (VIR) reported revenue of 303.23M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 303.23M | 65.17M | 71.86M | 84.07M | 1.62B | 1.10B |
| Other Revenue | 3.39M | 2.34M | 2.11M | |||
| Revenue | 303.23M | 68.56M | 74.20M | 86.18M | 1.62B | 1.10B |
| Cost of Revenue | 483.31M | 444.50M | 492.79M | 572.83M | 620.97M | 513.87M |
| Gross Profit | -180.09M | -375.95M | -418.59M | -486.65M | 994.83M | 581.54M |
| Selling, General & Admin | 99.38M | 92.07M | 119.03M | 174.44M | 161.76M | 160.79M |
| Operating Expenses | 99.38M | 92.07M | 119.03M | 174.44M | 161.76M | 160.79M |
| Operating Income | -279.47M | -468.02M | -537.62M | -661.09M | 833.07M | 420.75M |
| Interest & Investment Income | 33.32M | 40.24M | 71.81M | 86.99M | 28.09M | 439.00K |
| Other Non Operating Income (Expenses) | -1.27M | -409.00K | -2.22M | -8.99M | 4.26M | -9.44M |
| EBT Excluding Unusual Items | -247.41M | -428.19M | -468.03M | -583.09M | 865.42M | 411.75M |
| Merger & Restructuring Charges | 182.00K | -34.99M | -13.56M | |||
| Gain (Loss) on Sale of Investments | -3.16M | 1.73M | -5.53M | -21.89M | -111.14M | 138.05M |
| Asset Writedown | -14.55M | -9.66M | ||||
| Other Unusual Items | -720.00K | -11.49M | ||||
| Pretax Income | -251.30M | -437.77M | -523.11M | -628.19M | 754.28M | 549.80M |
| Income Tax Expense | 380.00K | 217.00K | -1.15M | -13.08M | 238.44M | 21.22M |
| Earnings From Continuing Operations | -251.68M | -437.99M | -521.96M | -615.12M | 515.84M | 528.58M |
| Minority Interest in Earnings | 56.00K | |||||
| Net Income | -251.68M | -437.99M | -521.96M | -615.06M | 515.84M | 528.58M |
| Net Income to Common | -251.68M | -437.99M | -521.96M | -615.06M | 515.84M | 528.58M |
| Shares Outstanding (Basic) | 148.35M | 138.52M | 136.25M | 134.13M | 132.61M | 129.88M |
| Shares Outstanding (Diluted) | 148.35M | 138.52M | 136.25M | 134.13M | 134.81M | 133.44M |
| EPS (Basic) | -1.70 | -3.16 | -3.83 | -4.59 | 3.89 | 4.07 |
| EPS (Diluted) | -1.70 | -3.16 | -3.83 | -4.59 | 3.83 | 3.96 |
| Free Cash Flow | -203.59M | -396.61M | -453.65M | -800.36M | 1.60B | -69.41M |
| Free Cash Flow Per Share | -1.37 | -2.86 | -3.33 | -5.97 | 11.83 | -0.52 |
| Gross Margin | -59.39% | 61.57% | 53.09% | |||
| Operating Margin | -92.16% | -682.68% | -724.51% | -767.10% | 51.56% | 38.41% |
| Profit Margin | -83.00% | -638.88% | -703.40% | -713.69% | 31.92% | 48.25% |
| Free Cash Flow Margin | -67.14% | -578.52% | -611.35% | -928.71% | 98.73% | -6.34% |
| EBITDA | -267.96M | -456.34M | -523.06M | -641.64M | 839.85M | 426.56M |
| EBITDA Margin | -88.37% | 51.98% | 38.94% | |||
| D&A For EBITDA | 11.51M | 11.68M | 14.56M | 19.45M | 6.78M | 5.81M |
| EBIT | -279.47M | -468.02M | -537.62M | -661.09M | 833.07M | 420.75M |
| EBIT Margin | -92.16% | 51.56% | 38.41% | |||
| Effective Tax Rate | 31.61% | 3.86% | ||||
| Revenue as Reported | 303.23M | 68.56M | 74.20M | 86.18M | 1.62B | 1.10B |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 278.73M | 232.19M | 222.95M | 241.58M | 848.63M | 347.81M |
| Short-Term Investments | 254.00M | 234.83M | 682.40M | 1.28B | 1.55B | 360.33M |
| Cash & Short-Term Investments | 532.73M | 467.01M | 905.35M | 1.52B | 2.40B | 708.14M |
| Accounts Receivable | 773.08M | |||||
| Other Receivables | 5.60M | 3.60M | 5.00M | 11.60M | 28.90M | |
| Receivables | 5.60M | 3.60M | 5.00M | 11.60M | 28.90M | 773.08M |
| Prepaid Expenses | 33.48M | 41.54M | 42.73M | 40.95M | 57.84M | 73.00M |
| Restricted Cash | 1.93M | 1.92M | 89.39M | 13.27M | 12.68M | 8.59M |
| Other Current Assets | 17.62M | |||||
| Total Current Assets | 573.74M | 514.08M | 1.04B | 1.59B | 2.52B | 1.56B |
| Property, Plant & Equipment | 109.82M | 117.72M | 122.86M | 167.20M | 188.17M | 130.05M |
| Long-Term Investments | 475.02M | 314.57M | 190.01M | 105.28M | 23.93M | 201.39M |
| Goodwill | 16.94M | 16.94M | 16.94M | 16.94M | 16.94M | 16.94M |
| Other Intangible Assets | 7.70M | 7.85M | 8.12M | 22.57M | 32.76M | 33.29M |
| Other Long-Term Assets | 31.59M | 31.66M | 18.42M | 18.86M | 21.23M | 9.78M |
| Total Assets | 1.21B | 1.00B | 1.40B | 1.92B | 2.80B | 1.95B |
| Accounts Payable | 17.75M | 9.80M | 5.08M | 6.33M | 6.42M | 6.52M |
| Accrued Expenses | 66.24M | 72.39M | 66.53M | 82.15M | 462.07M | 129.54M |
| Current Portion of Leases | 9.14M | 8.80M | 7.75M | 12.87M | 4.14M | 3.93M |
| Current Income Taxes Payable | 15.23M | 6.22M | ||||
| Current Unearned Revenue | 12.65M | 64.85M | 15.52M | 98.21M | ||
| Other Current Liabilities | 1.83M | 1.82M | 27.65M | 9.20M | 7.65M | 96.83M |
| Total Current Liabilities | 94.96M | 92.81M | 119.66M | 175.41M | 511.03M | 341.24M |
| Long-Term Leases | 84.14M | 89.05M | 90.14M | 111.67M | 123.84M | 133.56M |
| Long-Term Unearned Revenue | 53.21M | 3.81M | ||||
| Long-Term Deferred Tax Liabilities | 18.44M | |||||
| Other Long-Term Liabilities | 53.22M | 55.68M | 38.63M | 41.74M | 36.05M | 25.36M |
| Total Liabilities | 232.31M | 237.55M | 248.43M | 328.82M | 724.12M | 522.42M |
| Common Stock | 17.00K | 14.00K | 14.00K | 13.00K | 13.00K | 13.00K |
| Additional Paid-In Capital | 2.23B | 1.97B | 1.91B | 1.83B | 1.71B | 1.57B |
| Retained Earnings | -1.24B | -1.20B | -759.78M | -237.82M | 377.24M | -138.60M |
| Comprehensive Income & Other | -4.60M | -2.06M | -1.72M | -815.00K | -9.12M | -1.10M |
| Total Common Equity | 982.49M | 765.28M | 1.15B | 1.59B | 2.08B | 1.43B |
| Shareholders' Equity | 982.49M | 765.28M | 1.15B | 1.59B | 2.08B | 1.43B |
| Total Liabilities & Equity | 1.21B | 1.00B | 1.40B | 1.92B | 2.80B | 1.95B |
| Total Debt | 93.27M | 97.85M | 97.89M | 124.54M | 127.97M | 137.49M |
| Net Cash (Debt) | 439.45M | 369.16M | 807.46M | 1.40B | 2.27B | 570.66M |
| Net Cash Per Share | 2.96 | 2.67 | 5.93 | 10.42 | 16.87 | 4.28 |
| Filing Date Shares Outstanding | 169.22M | 139.52M | 137.14M | 135.03M | 133.53M | 132.30M |
| Total Common Shares Outstanding | 169.19M | 139.47M | 136.96M | 134.78M | 133.24M | 131.16M |
| Working Capital | 478.78M | 421.26M | 922.80M | 1.41B | 2.01B | 1.22B |
| Book Value Per Share | 5.81 | 5.49 | 8.40 | 11.80 | 15.60 | 10.92 |
| Tangible Book Value | 957.85M | 740.49M | 1.13B | 1.55B | 2.03B | 1.38B |
| Tangible Book Value Per Share | 5.66 | 5.31 | 8.22 | 11.51 | 15.22 | 10.53 |
| Machinery | 46.80M | 46.49M | 44.90M | 49.40M | 41.93M | 22.57M |
| Construction In Progress | 114.00K | 1.07M | 226.00K | 26.93M | ||
| Leasehold Improvements | 56.26M | 56.18M | 53.99M | 80.29M | 84.42M | 7.83M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -251.68M | -437.99M | -521.96M | -615.06M | 515.84M | 528.58M |
| Depreciation & Amortization | 11.51M | 11.68M | 14.56M | 19.45M | 6.78M | 5.81M |
| Asset Writedown & Restructuring Costs | 255.00K | 654.00K | 38.72M | 17.32M | ||
| Loss (Gain) From Sale of Investments | 6.74M | 7.75M | 10.93M | 13.18M | 102.20M | -138.29M |
| Stock-Based Compensation | 47.04M | 49.07M | 78.46M | 111.32M | 102.08M | 83.78M |
| Other Operating Activities | 6.29M | -498.00K | 16.27M | 7.72M | 270.99M | 100.92M |
| Change in Accounts Receivable | 770.04M | -773.08M | ||||
| Change in Accounts Payable | 5.64M | 5.00M | -988.00K | 732.00K | 797.00K | -171.00K |
| Change in Unearned Revenue | -33.30M | 92.04M | ||||
| Change in Other Net Operating Assets | -28.30M | -27.44M | -82.33M | -333.44M | -72.17M | 52.81M |
| Operating Cash Flow | -202.51M | -391.78M | -446.35M | -778.78M | 1.66B | -47.59M |
| Capital Expenditures | -1.09M | -4.83M | -7.30M | -21.57M | -68.01M | -21.82M |
| Sale of Property, Plant & Equipment | -73.00K | 253.00K | 3.37M | |||
| Investment in Securities | -57.05M | 314.95M | 503.30M | 186.20M | -1.13B | -119.00M |
| Investing Cash Flow | -58.21M | 310.37M | 499.37M | 164.63M | -1.19B | -140.81M |
| Long-Term Debt Repaid | -259.00K | |||||
| Net Debt Issued (Repaid) | -259.00K | |||||
| Issuance of Common Stock | 242.04M | 4.15M | 4.55M | 7.77M | 36.22M | 100.59M |
| Other Financing Activities | -1.00K | -361.00K | -165.00K | -287.00K | -1.46M | |
| Financing Cash Flow | 242.04M | 3.79M | 4.39M | 7.48M | 34.76M | 100.33M |
| Net Cash Flow | -18.68M | -77.62M | 57.40M | -606.68M | 504.55M | -88.07M |
| Free Cash Flow | -203.59M | -396.61M | -453.65M | -800.36M | 1.60B | -69.41M |
| Free Cash Flow Margin | -67.14% | -578.52% | -611.35% | -928.71% | 98.73% | -6.34% |
| Free Cash Flow Per Share | -1.37 | -2.86 | -3.33 | -5.97 | 11.83 | -0.52 |
| Levered Free Cash Flow | -38.89M | -174.44M | -372.22M | -597.12M | 1.47B | -246.55M |
| Unlevered Free Cash Flow | -38.89M | -174.44M | -372.22M | -597.12M | 1.47B | -246.55M |
| Cash Income Tax Paid | 2.42M | 2.42M | 252.03M | |||
| Change in Working Capital | -22.66M | -22.45M | -83.32M | -332.71M | 665.37M | -628.39M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.86B | 838.92M | 1.01B | 1.35B | 3.37B | 5.48B |
| Enterprise Value | 1.42B | 432.59M | 209.20M | -215.59M | 1.15B | 4.61B |
| Last Close Price | 11.00 | 6.03 | 7.34 | 10.06 | 25.31 | 41.87 |
| PE Ratio | 6.53 | 10.37 | ||||
| Forward PE | 92.73 | 92.73 | 92.73 | 92.73 | 18.86 | |
| PS Ratio | 6.14 | 12.24 | 13.62 | 15.70 | 2.08 | 5.00 |
| PB Ratio | 1.89 | 1.10 | 0.88 | 0.85 | 1.62 | 3.83 |
| P/TBV Ratio | 1.94 | 1.13 | 0.90 | 0.87 | 1.66 | 3.97 |
| P/FCF Ratio | 2.11 | |||||
| P/OCF Ratio | 2.03 | |||||
| EV/Sales Ratio | 4.69 | 6.31 | 2.82 | 0.71 | 4.21 | |
| EV/EBITDA Ratio | 1.37 | 10.81 | ||||
| EV/EBIT Ratio | 1.39 | 10.96 | ||||
| EV/FCF Ratio | 0.72 | |||||
| Debt / Equity Ratio | 0.10 | 0.13 | 0.09 | 0.08 | 0.06 | 0.10 |
| Debt / EBITDA Ratio | 0.15 | 0.31 | ||||
| Debt / FCF Ratio | 0.08 | |||||
| Net Debt / Equity Ratio | -0.45 | -0.48 | -0.70 | -0.88 | -1.09 | -0.40 |
| Net Debt / EBITDA Ratio | 1.64 | 0.81 | 1.54 | 2.18 | -2.71 | -1.34 |
| Net Debt / FCF Ratio | 2.16 | 0.93 | 1.78 | 1.75 | -1.43 | 8.22 |
| Asset Turnover | 0.25 | 0.06 | 0.04 | 0.04 | 0.68 | 0.76 |
| Quick Ratio | 5.67 | 5.07 | 7.61 | 8.74 | 4.76 | 4.34 |
| Current Ratio | 6.04 | 5.54 | 8.71 | 9.05 | 4.93 | 4.58 |
| Return on Equity (ROE) | -26.08% | -45.73% | -38.09% | -33.54% | 29.39% | 49.20% |
| Return on Assets (ROA) | -14.51% | -24.36% | -20.26% | -17.50% | 21.89% | 18.31% |
| Return on Invested Capital (ROIC) | -57.32% | -126.66% | -200.87% | -343.66% | 88.77% | |
| Return on Capital Employed (ROCE) | -25.00% | -51.40% | -42.00% | -37.90% | 36.40% | 26.10% |
| Earnings Yield | -15.44% | -52.21% | -51.63% | -45.45% | 15.31% | 9.65% |
| FCF Yield | -10.94% | -47.28% | -44.88% | -59.14% | 47.35% | -1.27% |
| Buyback Yield / Dilution | -8.01% | -1.67% | -1.58% | 0.50% | -1.03% | -11.98% |